Submitted by Anonymous (not verified) on 6 September 2023 - 14:15
Human medicines European public assessment report (EPAR): Poteligeo, mogamulizumab, Sezary Syndrome;Mycosis Fungoides, Date of authorisation: 22/11/2018, Revision: 6, Status: Authorised
Source: